ArticleParkinson's disease2020

Direct Cost of Parkinson's Disease: A Real-World Data Study of Second-Line Therapies.

Elisa Gomez-Inhiesto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.